These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32366727)

  • 21. Laboratory diagnosis for Covid-19: A mini-review.
    Pizzol JLD; Hora VPD; Reis AJ; Vianna J; Ramis I; Groll AV; Silva PAD
    Rev Soc Bras Med Trop; 2020; 53():e20200451. PubMed ID: 32876316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. India's COVID-19 Testing Strategy: Why Pediatric Hospitals Need to Focus More on ILI than SARI?
    Dash N; Awasthi PR; Nallasamy K
    Indian J Pediatr; 2020 Sep; 87(9):753. PubMed ID: 32519263
    [No Abstract]   [Full Text] [Related]  

  • 23. Refusing Testing During a Pandemic.
    Morris NP
    Am J Public Health; 2020 Sep; 110(9):1354-1355. PubMed ID: 32783720
    [No Abstract]   [Full Text] [Related]  

  • 24. Establishing a healthcare worker screening programme for COVID-19.
    Boustead K; McDowall K; Baker KF; Pareja-Cebrian L; Gibson L; Cunningham M; Murphy E
    Occup Med (Lond); 2020 Oct; 70(7):456-457. PubMed ID: 32569369
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening maternity populations during the COVID-19 pandemic.
    Iida M; Tanaka M
    BJOG; 2020 Nov; 127(12):1557. PubMed ID: 32735760
    [No Abstract]   [Full Text] [Related]  

  • 26. Unnecessary obstacles to COVID-19 mass testing.
    Peto J; Hunter DJ; Riboli E; Griffin JL
    Lancet; 2020 Nov; 396(10263):1633. PubMed ID: 33075304
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspective on oral exfoliative cytology and COVID-19.
    Mhaske S; Yuwanati M; Mhaske A; Desai A; Sarode SC; Sarode GS
    Oral Oncol; 2020 Aug; 107():104858. PubMed ID: 32561129
    [No Abstract]   [Full Text] [Related]  

  • 28. Interpreting the COVID-19 Test Results: A Guide for Physiatrists.
    Chang MC; Hur J; Park D
    Am J Phys Med Rehabil; 2020 Jul; 99(7):583-585. PubMed ID: 32427600
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostics and the coronavirus: don't let the standards slip.
    Page M; Almond N; Rose NJ; Schneider CK
    Nat Biotechnol; 2020 Jun; 38(6):673-674. PubMed ID: 32444851
    [No Abstract]   [Full Text] [Related]  

  • 30. Spit shines for easier coronavirus testing.
    Service RF
    Science; 2020 Aug; 369(6507):1041-1042. PubMed ID: 32855317
    [No Abstract]   [Full Text] [Related]  

  • 31. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 Sep; 16(706):1726. PubMed ID: 32936565
    [No Abstract]   [Full Text] [Related]  

  • 32. Pancytopenia during SARS-CoV-2 infection.
    Martín Pozuelo Ruiz de Pascual R; López Pardo P; López-Dóriga Bonnardeaux P
    Med Clin (Barc); 2020 Oct; 155(8):364-365. PubMed ID: 32753109
    [No Abstract]   [Full Text] [Related]  

  • 33. Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients.
    Goldfarb IT; Diouf K; Barth WH; Robinson JN; Katz D; Gregory KE; Ciaranello A; Yawetz S; Shenoy ES; Klompas M
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1095-1096. PubMed ID: 32456729
    [No Abstract]   [Full Text] [Related]  

  • 34. Virus Detection: What Were We Doing before COVID-19 Changed the World?
    Gooding JJ; Ligler FS
    ACS Sens; 2020 Jun; 5(6):1503-1504. PubMed ID: 32469511
    [No Abstract]   [Full Text] [Related]  

  • 35. How ADA methodology informs SARS-CoV-2 assay development.
    Becker C
    Bioanalysis; 2020 Sep; 12(18):1275-1277. PubMed ID: 32915061
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 testing in the UK.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2020 Nov; 8(11):1061. PubMed ID: 32976756
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19: Diagnostic Testing and Challenges.
    Ogbebor O; Min Z; Cheema T; Bhanot N
    Crit Care Nurs Q; 2020; 43(4):343-348. PubMed ID: 32833771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 and EBV coinfection.
    García-Martínez FJ; Moreno-Artero E; Jahnke S
    Med Clin (Barc); 2020 Oct; 155(7):319-320. PubMed ID: 32651071
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 40. Disposition of patients with coronavirus disease 2019 (COVID-19) whose respiratory specimens remain positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) by polymerase chain reaction assay (PCR).
    Mermel LA
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1326-1327. PubMed ID: 32517833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.